ARCHIVES

NCI Cooperative Group Clinical Trials Approved

This article is from The Cancer Letter archive.

Vol. 33 No. 4 | April 30, 2010

Download PDF Visit The Full Archive

Related Articles

Avastin Improves PFS Compared To Chemo Alone

January 29, 2010

PV-10 Produces 51 Percent Response Rate in Phase II Trial

October 26, 2012

In Brief: Peter Pisters named CEO of University Health Network in Toronto

August 8, 2014

FDA Backs Down, Releases INDs, But Revives Controversy Over Clinical Testing Guidelines

March 12, 1976

PSA Velocity Poor Predictor Of Prostate Cancer Occurrence

March 25, 2011

FDA Approves Bexxar For Treatment Of Non-Hodgkin’s Lymphoma.

July 4, 2003